Silver Mines Limited (SLVMF)
USD 0.09
(87.0%)
USD 0.09
(87.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.3 Million | -2.49 Million | -1.96 Million | -1.62 Million | -1.45 Million | -1.89 Million |
| Net Income | -2.21 Million | -4.11 Million | -13.29 Million | 5.35 Million | -3.74 Million | -1.79 Million |
| Depreciation & Amortization | 235.66 Thousand | 277.9 Thousand | 253.93 Thousand | 273.03 Thousand | 223.8 Thousand | 168.04 Thousand |
| Deferred income taxes | - | -434.79 Thousand | -387.11 Thousand | - | -321.16 Thousand | - |
| Stock-based compensation | 452.3 Thousand | 434.79 Thousand | 387.11 Thousand | - | 321.16 Thousand | - |
| Change in working capital | 59.43 Thousand | -184.67 Thousand | -125.26 Thousand | -17.09 Thousand | -144.22 Thousand | -222.66 Thousand |
| Other non-cash items | -831.51 Thousand | 1.09 Million | 10.82 Million | -7.24 Million | 1.89 Million | -48.84 Thousand |
| Investing Cash Flow | -8.39 Million | -23.26 Million | -13.15 Million | -9.15 Million | -11.08 Million | -5.29 Million |
| Investments in PPE | -13.73 Million | -22.96 Million | -15.41 Million | -11.25 Million | -11.1 Million | -5.35 Million |
| Acquisitions | - | 909.00 | -13.04 Million | 969 Thousand | 19.09 Thousand | 58.95 Thousand |
| Investment purchases | -10 Thousand | -1.3 Million | -80 Thousand | 9.22 Million | - | - |
| Sales/Maturities of investments | 5.32 Million | 1 Million | 501.51 Thousand | 1.12 Million | - | - |
| Other Investing Activities | -13.18 Million | -1.3 Million | 14.87 Million | -9.22 Million | 663.42 Thousand | 651.03 Thousand |
| Financing Cash Flow | 13.45 Million | 16.92 Million | 5.44 Million | 30.08 Million | 24.02 Million | 7.09 Million |
| Debt repayment | - | - | - | -1 Million | - | -1.01 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -549.13 Thousand | -1.08 Million | - | -1.86 Million | -1.56 Million | -593.66 Thousand |
| Common Stock Issuance | 14 Million | 16.92 Million | 5.44 Million | 30 Million | 24.84 Million | 6.69 Million |
| Other Financing Activities | 13.45 Million | 1.08 Million | 5.44 Million | 2.95 Million | 739.14 Thousand | 3.01 Million |
| Accounts receivables | 107.75 Thousand | 52.08 Thousand | -62.54 Thousand | -110.87 Thousand | -94.56 Thousand | -47.5 Thousand |
| Accounts payables | - | -4794.00 | 103.05 Thousand | 74.1 Thousand | -4420.00 | -236.26 Thousand |
| Inventory | -54.33 Thousand | -231.96 Thousand | -165.76 Thousand | 19.68 Thousand | -45.24 Thousand | 61.09 Thousand |
| Other working capital | 6017.00 | 41.8 Thousand | 1.00 | - | - | - |
| Cash at beginning of period | 8.05 Million | 16.89 Million | 31.42 Million | 12.12 Million | 633.82 Thousand | 730.67 Thousand |
| Cash at end of period | 10.8 Million | 8.05 Million | 16.89 Million | 31.42 Million | 12.12 Million | 633.82 Thousand |
| Capital Expenditure | -13.73 Million | -22.96 Million | -15.41 Million | -11.25 Million | -11.1 Million | -5.35 Million |
| Effect of forex changes on cash | - | -1.00 | -4.86 Million | - | - | - |
| Net cash flow / Change in cash | 2.75 Million | -8.83 Million | -14.53 Million | 19.29 Million | 11.49 Million | -96.85 Thousand |
| Free Cash Flow | -16.03 Million | -25.45 Million | -17.37 Million | -12.88 Million | -12.55 Million | -7.25 Million |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -819.06 Thousand | -819.06 Thousand | -289.73 Thousand | -289.73 Thousand | -4.11 Million | -2.6 Million |
| Depreciation & Amortization | 53.57 Thousand | 53.57 Thousand | 64.26 Thousand | 64.26 Thousand | 277.9 Thousand | 141 Thousand |
| Deferred income taxes | - | - | - | - | -434.79 Thousand | -254.03 Thousand |
| Stock-based compensation | 163.7 Thousand | 163.7 Thousand | 62.44 Thousand | 62.44 Thousand | 434.79 Thousand | 41.06 Thousand |
| Change in working capital | 29.71 Thousand | 29.71 Thousand | - | - | -184.67 Thousand | -69.03 Thousand |
| Other non-cash items | 134.54 Thousand | 134.54 Thousand | -550.3 Thousand | -550.3 Thousand | 1.09 Million | 1.35 Million |
| Investing Cash Flow | -2.58 Million | -2.58 Million | -1.61 Million | -1.61 Million | -23.26 Million | -11.51 Million |
| Investments in PPE | 566.52 Thousand | 566.52 Thousand | -830.94 Thousand | -830.94 Thousand | -22.96 Million | -11.51 Million |
| Acquisitions | - | - | 5.32 Million | - | 909.00 | 909.00 |
| Investment purchases | - | - | - | - | -1.3 Million | 1.3 Million |
| Sales/Maturities of investments | - | - | - | - | 1 Million | - |
| Other Investing Activities | -3.14 Million | -3.14 Million | -785.06 Thousand | -785.06 Thousand | -1.3 Million | -1.3 Million |
| Financing Cash Flow | 6.72 Million | 6.72 Million | - | - | 16.92 Million | 16.92 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -1.08 Million | - |
| Common Stock Issuance | - | - | - | - | 16.92 Million | 16.92 Million |
| Other Financing Activities | 6.72 Million | 6.72 Million | - | - | 1.08 Million | 8.46 Million |
| Accounts receivables | 53.87 Thousand | 53.87 Thousand | - | - | 52.08 Thousand | 26.04 Thousand |
| Accounts payables | - | - | - | - | -4794.00 | - |
| Inventory | -27.16 Thousand | -27.16 Thousand | - | - | -231.96 Thousand | -115.98 Thousand |
| Other working capital | 3009.00 | 3009.00 | - | - | 41.8 Thousand | 20.9 Thousand |
| Cash at beginning of period | - | - | 8.05 Million | - | 16.89 Million | 4.03 Million |
| Cash at end of period | 3.7 Million | 3.7 Million | 3.39 Million | -2.32 Million | 8.05 Million | 8.05 Million |
| Capital Expenditure | 566.52 Thousand | 566.52 Thousand | -830.94 Thousand | -830.94 Thousand | -22.96 Million | -11.51 Million |
| Effect of forex changes on cash | - | - | - | - | -1.00 | - |
| Net cash flow / Change in cash | 3.7 Million | 3.7 Million | -4.65 Million | -2.32 Million | -8.83 Million | 4.01 Million |
| Free Cash Flow | 128.99 Thousand | 128.99 Thousand | -1.54 Million | -1.54 Million | -25.45 Million | -12.9 Million |
DRMA
TROX
000678
EICHERMOT
120110
301160